Endodiag

Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease. With its EndoGram prognosis program, Endodiag contributes to improving current diagnostic practice by providing additional biological information for personalized medical and therapeutic management for each patient. In parallel, the company develops a new non-invasive diagnostic test (EndoDTect), making endometriosis detection much easier and faster. Finally, Endodiag offers drug testing services to pharmaceutical companies enabling them to make the early in-vitro evaluation of drug efficacy of cell lines and patient-derived cell cultures.